Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
1 May 2019
UCB and University of Lille anti-tau immunotherapy research highlighted in prestigious international scientific journal ‘Brain’
Read More
25 Apr 2019
UCB's General Meeting of Shareholders
Read More
24 Apr 2019
New Data Showcases the Value of CIMZIA® (certolizumab pegol) in Patients with Psoriasis
Read More
10 Apr 2019
Transparency notification BlackRock, Inc.
Read More
9 Apr 2019
FDA Approves Evenity™ (Romosozumab) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
Read More
8 Apr 2019
Transparency notification BlackRock, Inc.
Read More
4 Apr 2019
Acquisition of own shares
Read More
2 Apr 2019
Transparency notifications BlackRock, Inc.
Read More
31 Mar 2019
UCB to provide additional information to the US FDA regarding midazolam nasal spray submission
Read More
29 Mar 2019
Transparency notification BlackRock, Inc.
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
20
Page
21
Page
22
Page
23
Current page
24
Page
25
Page
26
Page
27
Page
28
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss